Simona Montilla

MONITORING REGISTRIES AT ITALIAN MEDICINES AGENCY: FOSTERING ACCESS, GUARANTEEING SUSTAINABILITY

Americo Cicchetti, Entela Xoxi, Luca Pani, 2015, International Journal of Technology Assessment in Health Care.

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study.

L. Pani, R. Bruno, A. Alberti, 2017, The lancet. Gastroenterology & hepatology.

Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.

L. Pani, G. Marchesini, D. Melchiorri, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes

L. Pani, G. Pietrosi, G. Cordone, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real‐life experience

L. Pani, U. Visco-Comandini, P. Caraceni, 2018, Liver international : official journal of the International Association for the Study of the Liver.

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries

M. Buti, L. Gheorghe, A. Craxì, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?

A. Gasbarrini, M. Massari, A. Andriulli, 2018, Liver international : official journal of the International Association for the Study of the Liver.